Specialty pharma, vertically integrated. We hold the marketing authorisation, manage the supply chain, and own the licensed pharmacy that puts medicine in the patient’s hand. One company across the full chain.
Every year, more essential medicines disappear from the European market. Not because they stop working — because no company is willing to own them. Volume too low. Margin too thin. Regulatory burden too tedious.
We started Octopus Health to be the company that is willing.
Every stage from regulatory authorisation to the moment a pharmacist hands medicine to a patient runs through one organisation. No subcontractors. No handoffs. No gaps.
Some medicines never made it onto a blockbuster trajectory — and never will. Volumes in the low thousands. Patents long expired. A registration in 14 jurisdictions to maintain. A patient population small enough to fit in one room — and depending on the molecule completely.
They sit in big-pharma portfolios as candidates for divestment. They sit in smaller portfolios as products too important to drop and too expensive to scale. Either way, they need someone who actually wants them.
That’s us. We’re in love with the medicines that help the people who need them most — even when the economics are difficult, the registrations are scattered, and the volumes will never be a headline. We carry them. We keep them registered. We make sure they reach the patients who depend on them.
→ If you’re responsible for one of these medicines — talk to us.A marketing authorisation. A batch release. A pharmacy dispense. A pharmacovigilance signal. Most companies hold one of these. We hold all four — for every product on our list.
Pharmacist-founded. Each founder owns one third of the company and one quarter of the chain end-to-end. When you work with Octopus Health, you work with the three of us.
ANDRIESRegistered pharmacist. Drives commercial strategy, in-licensing economics, and the company's growth path. Bridges scientific reality and commercial discipline — the founder who keeps the deals real.
in/andries-kevenaar →
TAKORegistered pharmacist. Holds every marketing authorisation in the portfolio. Manages CMC strategy, regulatory compliance, and serves as the scientific authority across all jurisdictions.
in/tako-mulder →
JOOSTLeads acquisition origination — the conversations with large pharma about products being divested. Negotiates deal economics, structures the transfer, and drives portfolio growth.
in/joost-komijn →Divesting a portfolio. Acquiring a niche product. Struggling with supply for low-volume medicines. Whatever the situation — write to us and we’ll write back.